[go: up one dir, main page]

DK36291D0 - Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser - Google Patents

Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser

Info

Publication number
DK36291D0
DK36291D0 DK036291A DK36291A DK36291D0 DK 36291 D0 DK36291 D0 DK 36291D0 DK 036291 A DK036291 A DK 036291A DK 36291 A DK36291 A DK 36291A DK 36291 D0 DK36291 D0 DK 36291D0
Authority
DK
Denmark
Prior art keywords
piperidyl
treatment
application
cognitive disorders
index derivatives
Prior art date
Application number
DK036291A
Other languages
English (en)
Inventor
Brenda Costall
Jens Kristian Perregaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to DK036291A priority Critical patent/DK36291D0/da
Publication of DK36291D0 publication Critical patent/DK36291D0/da
Priority to IE920572A priority patent/IE70600B1/en
Priority to ZA921462A priority patent/ZA921462B/xx
Priority to CA002105385A priority patent/CA2105385C/en
Priority to IL10110292A priority patent/IL101102A/en
Priority to EP92906578A priority patent/EP0575429B1/en
Priority to JP04505932A priority patent/JP3108434B2/ja
Priority to AT92906578T priority patent/ATE131055T1/de
Priority to DE69206607T priority patent/DE69206607T2/de
Priority to DK92906578.7T priority patent/DK0575429T3/da
Priority to PCT/DK1992/000063 priority patent/WO1992015303A1/en
Priority to AU13707/92A priority patent/AU663699B2/en
Priority to KR1019930702618A priority patent/KR0183424B1/ko
Priority to NZ241800A priority patent/NZ241800A/en
Priority to NO933091A priority patent/NO307406B1/no
Priority to US08/115,449 priority patent/US5444073A/en
Priority to HK98102377A priority patent/HK1003560A1/xx
Priority to CY9802083A priority patent/CY2083B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Meat And Fish (AREA)
DK036291A 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser DK36291D0 (da)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
IE920572A IE70600B1 (en) 1991-03-01 1992-02-24 Treatment of cognitive disorders
ZA921462A ZA921462B (en) 1991-03-01 1992-02-27 Treatment of cognitive disorders
KR1019930702618A KR0183424B1 (ko) 1991-03-01 1992-02-28 인식력 장애 치료용 약학적 제제
DE69206607T DE69206607T2 (de) 1991-03-01 1992-02-28 Behandlung von kognitiven störungen.
PCT/DK1992/000063 WO1992015303A1 (en) 1991-03-01 1992-02-28 Treatment of cognitive disorders
EP92906578A EP0575429B1 (en) 1991-03-01 1992-02-28 Treatment of cognitive disorders
JP04505932A JP3108434B2 (ja) 1991-03-01 1992-02-28 認識障害の治療法
AT92906578T ATE131055T1 (de) 1991-03-01 1992-02-28 Behandlung von kognitiven störungen.
CA002105385A CA2105385C (en) 1991-03-01 1992-02-28 Treatment of cognitive disorders
DK92906578.7T DK0575429T3 (da) 1991-03-01 1992-02-28 Behandlings af kognitive lidelser
IL10110292A IL101102A (en) 1991-03-01 1992-02-28 Phar aceut cal p epara ion f r the treatment of cognitive disorders containing 3-piperidyl-indole derivatives
AU13707/92A AU663699B2 (en) 1991-03-01 1992-02-28 Treatment of cognitive disorders
NZ241800A NZ241800A (en) 1991-03-01 1992-03-02 Use of 1-aryl-3-(4-piperidyl)indole derivatives to treat cognitive disorders
NO933091A NO307406B1 (no) 1991-03-01 1993-08-31 Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
US08/115,449 US5444073A (en) 1991-03-01 1993-09-01 Method for treating memory impairment
HK98102377A HK1003560A1 (en) 1991-03-01 1998-03-20 Treatment of cognitive disorders
CY9802083A CY2083B1 (en) 1991-03-01 1998-10-16 Treatment of cognitive disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser

Publications (1)

Publication Number Publication Date
DK36291D0 true DK36291D0 (da) 1991-03-01

Family

ID=8092662

Family Applications (2)

Application Number Title Priority Date Filing Date
DK036291A DK36291D0 (da) 1991-03-01 1991-03-01 Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
DK92906578.7T DK0575429T3 (da) 1991-03-01 1992-02-28 Behandlings af kognitive lidelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92906578.7T DK0575429T3 (da) 1991-03-01 1992-02-28 Behandlings af kognitive lidelser

Country Status (17)

Country Link
US (1) US5444073A (da)
EP (1) EP0575429B1 (da)
JP (1) JP3108434B2 (da)
KR (1) KR0183424B1 (da)
AT (1) ATE131055T1 (da)
AU (1) AU663699B2 (da)
CA (1) CA2105385C (da)
CY (1) CY2083B1 (da)
DE (1) DE69206607T2 (da)
DK (2) DK36291D0 (da)
HK (1) HK1003560A1 (da)
IE (1) IE70600B1 (da)
IL (1) IL101102A (da)
NO (1) NO307406B1 (da)
NZ (1) NZ241800A (da)
WO (1) WO1992015303A1 (da)
ZA (1) ZA921462B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
ES2326078T3 (es) 2002-08-22 2009-09-30 Dainippon Sumitomo Pharma Co., Ltd. Medicamento destinado al sindrome de la disfuncion de integracion.
JP4624261B2 (ja) * 2003-06-23 2011-02-02 大日本住友製薬株式会社 老人性痴呆症治療剤
US20070160537A1 (en) 2004-02-20 2007-07-12 Takeo Ishiyama In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48508A (en) * 1974-12-09 1979-10-31 Roussel Uclaf Pharmaceutical compositions comprising piperidylindole derivatives
FR2362628A1 (fr) * 1976-08-26 1978-03-24 Roussel Uclaf Nouveaux derives du piperidyl-indole et leurs sels, procede de preparation et application a titre de medicaments
SE8004129L (sv) * 1979-07-13 1981-01-14 Roussel Uclaf Nya tetrahydropyridin-4-yl-indolderivat samt salter derav, framstellning och anvendning derav sasom lekemedel samt kompositioner innehallande dessa foreningar
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8704572D0 (en) * 1987-02-26 1987-04-01 Lundbeck & Co As H Organic compounds
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater

Also Published As

Publication number Publication date
HK1003560A1 (en) 1998-10-30
IL101102A (en) 1996-03-31
JP3108434B2 (ja) 2000-11-13
KR930702978A (ko) 1993-11-29
ATE131055T1 (de) 1995-12-15
IE70600B1 (en) 1996-12-11
EP0575429A1 (en) 1993-12-29
WO1992015303A1 (en) 1992-09-17
AU663699B2 (en) 1995-10-19
CA2105385C (en) 2000-08-15
NO933091D0 (no) 1993-08-31
IL101102A0 (en) 1992-11-15
NZ241800A (en) 1997-03-24
US5444073A (en) 1995-08-22
AU1370792A (en) 1992-10-06
DE69206607D1 (de) 1996-01-18
CY2083B1 (en) 1998-10-16
CA2105385A1 (en) 1992-09-02
JPH06504787A (ja) 1994-06-02
EP0575429B1 (en) 1995-12-06
NO307406B1 (no) 2000-04-03
DK0575429T3 (da) 1996-04-22
KR0183424B1 (ko) 1999-05-01
IE920572A1 (en) 1992-09-09
NO933091L (no) 1993-11-01
ZA921462B (en) 1992-11-25
DE69206607T2 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
MY117896A (en) Quinazoline derivatives
DK0778834T3 (da) Bicykliske, heterocykliske diarylforbindelser som inhibitorer af cyclooxygenase-2
PT828724E (pt) Diaril-5-oxigenadas-2-(5h)-furanonas comoinibidoras de cox-2
NO974163L (no) Ester av 5-aminolevulinsyre som fotosensibiliserings-middel i fotokjemoterapi
HUP9904361A2 (hu) Izobutil-gaba és származékai alkalmazása fájdalom kezelésére
DK36291D0 (da) Anvendelse af piperidylsubstituerede indolderivater til behandling af kognitive lidelser
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
ES2053668T3 (es) Derivados de poliamina como agentes antineoplasicos.
WO2003013424A3 (en) Use of r-nsaid compounds for anti-hiv treatment
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
ATE216233T1 (de) Indolditerpen alkaloide
SE9900190D0 (sv) New compounds
DK1082116T3 (da) Anvendelse af 4-piperidinmethanolderivater til behandling af neurologiske sygdomme
ATE135217T1 (de) Pharmazeutische zusammensetzungen zur aids- behandlung
DK0814813T3 (da) Anvendelse af penciclovir til behandling af human herpesvirus-8
DE3884878D1 (de) Uricosuretische Zusammensetzung.
DK0772438T3 (da) Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
IT1245631B (it) Impiego di composti macrolidi come agenti anti-infiammatori per il trattamento di malattie provocate da cessione di istamina

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment